Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
<p>Abstract</p> <p>Background</p> <p>The multi-arm multi-stage (MAMS) trial is a new paradigm for conducting randomised controlled trials that allows the simultaneous assessment of a number of research treatments against a single control arm. MAMS trials provide earlier...
Main Authors: | Dearnaley David P, Clarke Noel W, James Nicholas D, Parmar Mahesh KB, Sydes Matthew R, Mason Malcolm D, Morgan Rachel C, Sanders Karen, Royston Patrick |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-06-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/10/1/39 |
Similar Items
-
Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial
by: Sydes Matthew R, et al.
Published: (2011-12-01) -
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
by: Sydes Matthew R, et al.
Published: (2012-09-01) -
The importance of lymph node location, burden and treatment outcome in M1 HSPC: analysis from the STAMPEDE trial arms A and C
by: Á.M. Haran, et al.
Published: (2020-09-01) -
How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design – a reanalysis of 4 trials
by: Barthel FM-S, et al.
Published: (2009-04-01) -
STAMPEDEing metastatic prostate cancer: CHAARTing the LATITUDEs
by: Aditya Prakash Sharma, et al.
Published: (2018-01-01)